Metraipolis › archive › dc_8aef0423406d

Novel insights into breast cancer copy number genetic heterogeneity revealed by single-cell genome sequencing — Europe PMC PMID:32401198

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/32401198
DOI
10.7554/elife.51480
License (as archived)
CC0-1.0
Archived
2026-11-08T17:24:58.263Z
SHA-256 of the archived text
69ca6dad321f74014c188baccf3bb164118e92542cbd4e579160dc81d39a0c50
Stable URL of this page
https://metraipolis.com/documento/dc_8aef0423406d

How to cite

Novel insights into breast cancer copy number genetic heterogeneity revealed by single-cell genome sequencing — Europe PMC PMID:32401198 — Europe PMC (en), https://europepmc.org/article/MED/32401198 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_8aef0423406d (Metraipolis archive dc_8aef0423406d, sha256 69ca6dad321f74014c188baccf3bb164118e92542cbd4e579160dc81d39a0c50)
BibTeX
@misc{dc8aef0423406d,
  title = {Novel insights into breast cancer copy number genetic heterogeneity revealed by single-cell genome sequencing — Europe PMC PMID:32401198},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/32401198},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_8aef0423406d; sha256 69ca6dad321f74014c188baccf3bb164118e92542cbd4e579160dc81d39a0c50},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/32401198. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Copy number alterations (CNAs) play an important role in molding the genomes of breast cancers and have been shown to be clinically useful for prognostic and therapeutic purposes. However, our knowledge of intra-tumoral genetic heterogeneity of this important class of somatic alterations is limited. Here, using single-cell sequencing, we comprehensively map out the facets of copy number alteration heterogeneity in a cohort of breast cancer tumors. Ou/var/www/html/elife/12-05-2020/backup/r analyses reveal: genetic heterogeneity of non-tumor cells (i.e. stroma) within the tumor mass; the extent to which copy number heterogeneity impacts breast cancer genomes and the importance of both the genomic location and dosage of sub-clonal events; the pervasive nature of genetic heterogeneity of chromosomal amplifications; and the association of copy number heterogeneity with clinical and biological parameters such as polyploidy and estrogen receptor negative status. Our data highlight the power of single-cell genomics in dissecting, in its many forms, intra-tumoral genetic heterogeneity of CNAs, the magnitude with which CNA heterogeneity affects the genomes of breast cancers, and the potential importance of CNA heterogeneity in phenomena such as therapeutic resistance and disease relapse.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: eLife, 2020 (prima pubblicazione 2020-05-13).
Identificativi: PMID 32401198 · PMCID PMC7220379 · DOI 10.7554/elife.51480.
Parole chiave degli autori: Human; Genetics; Cancer; Breast cancer; Genomics; Cancer Biology; Copy Number Alterations; Single-cell Sequencing.
Descrittori MeSH principali: Genomics; Gene Dosage; Genetic Heterogeneity; DNA Copy Number Variations; Single-Cell Analysis; Whole Genome Sequencing.
Pagina: https://europepmc.org/article/MED/32401198 — https://doi.org/10.7554/elife.51480. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-08T17:20:54.432Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.